Brief: Cytodyn Files New Protocol With U.S. FDA For 4 Doses Of Leronlimab For Critically Ill COVID-19 Patients

Cytodyn

01/04/2021 11:56

April 1 (Reuters) - Cytodyn Inc  CYDY.PK :
    * CYTODYN FILES NEW PROTOCOL WITH U.S. FDA FOR 4 DOSES OF
LERONLIMAB FOR CRITICALLY ILL COVID-19 PATIENTS WITH THE
OBJECTIVE TO DUPLICATE OR SURPASS 82% SURVIVAL BENEFIT WITH
P-VALUE OF 0.0233 ORIGINALLY ACHIEVED FROM TWO WEEKS OF
TREATMENT IN CD12 TRIAL WITH 2 DOSES

Source text for Eikon:  ID:nGNX7W98z3 
Further company coverage:  CYDY.PK 

 ((Reuters.Briefs@thomsonreuters.com;))